Class II — Appliedvr
| Recalling firm | AppliedVR |
|---|---|
| Registered facility | APPLIEDVR (the firm's only registered facility) |
| Classification | Class II |
| Status | Completed |
| Reason | There is the potential for the program software to malfunction which will not allow it to move forward to the next session. |
| Product | RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief. |
| Quantity | 1 unit |
| Distribution | US: NY OUS: None |
| Initiated | 2023-02-27 |
| Classified | 2023-06-29 |
| Recall number | Z-2044-2023 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — Appliedvr (Z-2044-2023).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/92389/
Alerts for AppliedVR
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.